AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Warby Parker Inc (NYSE:WRBY)
24.22 USD
-0.870 3.468%Sponsored Reports
Loading...
| Previous Close (in USD) | 25.09 |
|---|---|
| Change | -0.870 3.468% |
| 52 W H/L (in USD) | 17.880/9.500 |
| EBITDA (in USD) | -35.036M |
| PE Ratio | -- |
| Volume | 2171112 |
| Diluted Eps TTM | -0.56 |
| Total Assets (in USD) | 568.707M |
|---|---|
| Total Liabilities (in USD) | 282.061M |
| Revenue TTM (in USD) | 654.403M |
| Cash (in USD) | 208.585M |
| Market Cap (in USD) | 1,617.550 M |
| Revenue Per Share TTM | 5.609 |
| Gross Profit TTM (in USD) | 341.062M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Warby Parker Inc
Warby Parker Inc. provides eyewear products. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Employees: 1860
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Neil Harris Blumenthal | Co-Founder, Pres, Co-CEO & Co-Chair | 1981 |
| 2. | Mr. David Abraham Gilboa | Co-Founder, Co-CEO & Co-Chair | 1982 |
| 3. | Mr. Andrew M. Hunt | Co-Founder & Independent Director | NA |
| 4. | Mr. Jeff Raider | Co-Founder & Independent Director | NA |
| 5. | Mr. Steve Miller | Sr. VP & CFO | NA |
| 6. | Ms. Stephanie Pullings Hart | Sr. VP of Operations | 1974 |
| 7. | Mr. Jeffrey Saunders | Sr. VP & CTO | NA |
| 8. | Ms. Tina Romani | VP of Investor Relations | NA |
| 9. | Ms. Lori Krauss | Sr. VP & Chief Marketing Officer | NA |
| 10. | Ms. Chelsea Kaden | Sr. VP & Head of People | NA |
Peers
Sector: Healthcare
Industry: Medical Instruments & Supplies
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ISRG
Intuitive Surgical Inc |
+4.990 1.240% | 400.495 | 73.050 | 61.728 | 19.145 | 10.247 | 18.408 | 59.920 |
|
ESLOF
EssilorLuxottica Société anonyme |
0.000 0.000% | 198.5 | 44.840 | 27.624 | 4.068 | 2.492 | 3.715 | 16.038 |
|
ESLOY
Essilor International SA |
-0.980 0.988% | 98.84 | 41.680 | 27.248 | 3.943 | 2.454 | 3.715 | 16.038 |
|
BDX
Becton Dickinson and Company |
+1.180 0.817% | 144.46 | 25.560 | 12.484 | 2.589 | 1.763 | 2.890 | 12.552 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Income Before Tax | -109.896M | -144.008M | -55.729M | 0.276M |
| Minority Interest | - | - | - | - |
| Net Income | -110.393M | -144.271M | -55.919M | 0M |
| Selling General Administrative | 452.265M | 461.41M | 287.567M | 224.771M |
| Gross Profit | 341.062M | 317.749M | 231.935M | 223.108M |
| Reconciled Depreciation | 31.864M | 21.868M | 18.377M | 14.516M |
| Ebit | -111.203M | -143.661M | -55.632M | -1.663M |
| Ebitda | -79.339M | -121.793M | -37.255M | 12.853M |
| Depreciation And Amortization | 31.864M | 21.868M | 18.377M | 14.516M |
| Operating Income | -111.203M | -143.661M | -55.632M | -1.663M |
| Other Operating Expenses | 709.315M | 684.459M | 449.351M | 372.126M |
| Interest Expense | -1.307M | 0.347M | 0.097M | 1.939M |
| Tax Provision | 0.497M | 0.263M | 0.19M | 0.276M |
| Interest Income | - | - | - | - |
| Net Interest Income | 1.307M | -0.347M | -0.097M | 1.939M |
| Income Tax Expense | 0.497M | 0.263M | 0.19M | 0.276M |
| Total Revenue | 598.112M | 540.798M | 393.719M | 370.463M |
| Total Operating Expenses | 452.265M | 461.41M | 287.567M | 224.771M |
| Cost Of Revenue | 257.05M | 223.049M | 161.784M | 147.355M |
| Total Other Income Expense Net | 1.307M | -0.347M | -0.097M | 1.939M |
| Net Income From Continuing Ops | -110.393M | -144.271M | -55.919M | 0M |
| Net Income Applicable To Common Shares | -110.393M | -157.408M | -55.919M | -57.537M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Total Assets | 568.707M | 440.646M | 444.751M | 175.856M |
| Intangible Assets | - | - | - | - |
| Other Current Assets | 15.7M | 13.477M | 6.779M | 6.705M |
| Total Liab | 282.061M | 154.648M | 136.338M | 102.46M |
| Total Stockholder Equity | 286.646M | 285.998M | 308.413M | 73.396M |
| Other Current Liab | 60.592M | 4.301M | 3.722M | 2.958M |
| Common Stock | 0.012M | 0.011M | 0.005M | 0.005M |
| Capital Stock | 0.012M | 0.011M | 506.515M | 262.854M |
| Retained Earnings | -603.634M | -493.241M | -325.39M | -269.471M |
| Good Will | - | - | - | - |
| Other Assets | 8.497M | 0.471M | 0.284M | 0.282M |
| Cash | 208.585M | 256.416M | 314.085M | 55.424M |
| Cash And Equivalents | - | - | - | - |
| Total Current Liabilities | 129.557M | 118.104M | 105.33M | 75.867M |
| Current Deferred Revenue | 25.628M | 22.073M | 26.55M | 19.249M |
| Net Debt | -35.207M | -256.416M | -314.085M | -55.424M |
| Short Term Debt | 22.546M | 60.84M | 34.27M | 16.354M |
| Short Long Term Debt | - | - | - | - |
| Short Long Term Debt Total | 173.378M | - | - | - |
| Other Stockholder Equity | 890.915M | 338.566M | 127.179M | 79.991M |
| Property Plant Equipment | 254.342M | 112.195M | 80.934M | 80.19M |
| Total Current Assets | 294.568M | 327.98M | 359.933M | 91.684M |
| Long Term Investments | - | - | - | - |
| Short Term Investments | - | - | - | - |
| Net Receivables | 1.435M | 0.992M | 0.601M | 1.118M |
| Long Term Debt | - | - | - | - |
| Inventory | 68.848M | 57.095M | 38.468M | 28.437M |
| Accounts Payable | 20.791M | 30.89M | 40.788M | 37.306M |
| Accumulated Other Comprehensive Income | -0.647M | 0.016M | 0.109M | 0.022M |
| Non Currrent Assets Other | 8.497M | 0.471M | 0.284M | 0.282M |
| Non Current Assets Total | 274.139M | 112.666M | 84.818M | 84.172M |
| Capital Lease Obligations | 173.378M | - | - | - |
| Long Term Debt Total | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|
| Investments | -60.181M | -48.513M | -20.07M | -32.632M |
| Total Cashflows From Investing Activities | -60.181M | -48.513M | -20.07M | -32.632M |
| Total Cash From Financing Activities | 3.291M | 22.999M | 245.936M | -83.362M |
| Net Income | -110.393M | -144.271M | -55.919M | 0M |
| Change In Cash | -47.831M | -57.669M | 258.661M | -94.363M |
| Begin Period Cash Flow | 256.416M | 314.085M | 55.424M | 149.787M |
| End Period Cash Flow | 208.585M | 256.416M | 314.085M | 55.424M |
| Total Cash From Operating Activities | 10.37M | -31.994M | 32.758M | 21.394M |
| Depreciation | 31.864M | 21.868M | 18.377M | 14.516M |
| Other Cashflows From Investing Activities | - | - | - | - |
| Dividends Paid | - | - | - | - |
| Change To Inventory | -11.794M | -18.624M | -10.02M | -12.61M |
| Sale Purchase Of Stock | 0M | -8.085M | 0M | -79.474M |
| Other Cashflows From Financing Activities | 0.547M | 31.084M | 276.836M | -3.888M |
| Capital Expenditures | 60.181M | 48.513M | 20.07M | 32.632M |
| Change In Working Capital | -14.55M | -24.496M | 25.387M | -1.621M |
| Other Non Cash Items | 5.417M | 7.757M | - | - |
| Free Cash Flow | -49.811M | -80.507M | 12.688M | -11.238M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Fidelity® Series Blue Chip Growth | 2 years ago | 937179 |
| 2. | Fidelity® Small Cap Index | 2 years ago | 796539 |
| 3. | iShares Russell 2000 Growth ETF | 2 years ago | 748991 |
| 4. | Fidelity BlueChip Growth Commingled Pl A | 2 years ago | 716814 |
| 5. | Baillie Gifford Sustainable Growth | 2 years ago | 634523 |
| 6. | Baillie Gifford Sustainable Growth B Acc | 2 years ago | 631067 |
| 7. | T. Rowe Price Health Sciences | 2 years ago | 615911 |
| 8. | TIAA-CREF Quant Small-Cap Equity Instl | 2 years ago | 515420 |
| 9. | Fidelity® Blue Chip Growth | 2 years ago | 5561505 |
| 10. | Vanguard Total Stock Mkt Idx Inv | 2 years ago | 2577087 |
| 11. | T. Rowe Price Small-Cap Stock | 2 years ago | 2319324 |
| 12. | T. Rowe Price US Small-Cap Core Equity | 2 years ago | 2319324 |
| 13. | Vanguard Small Cap Index | 2 years ago | 2144870 |
| 14. | iShares Russell 2000 ETF | 2 years ago | 2017574 |
| 15. | Vanguard Small Cap Growth Index Inv | 2 years ago | 1206067 |
| 16. | T. Rowe Price U.S. SC Core Eq Tr-Z | 2 years ago | 1167944 |
| 17. | Fidelity® Blue Chip Growth K6 | 2 years ago | 1150436 |
| 18. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 1079797 |
| 19. | T. Rowe Price Science & Tech | 2 years ago | 1068604 |
| 20. | T. Rowe Price Instl Small-Cap Stock | 2 years ago | 1061626 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | D1 Capital Partners L.P. | 2 years ago | 14944023 |
| 2. | Durable Capital Partners LP | 2 years ago | 9641933 |
| 3. | FMR Inc | 2 years ago | 9277969 |
| 4. | Vanguard Group Inc | 2 years ago | 7850634 |
| 5. | BlackRock Inc | 2 years ago | 6948829 |
| 6. | Baillie Gifford & Co Limited. | 2 years ago | 6051671 |
| 7. | General Catalyst Group Management, LLC | 2 years ago | 5656571 |
| 8. | T. Rowe Price Investment Management,Inc. | 2 years ago | 5085053 |
| 9. | T. Rowe Price Associates, Inc. | 2 years ago | 2398570 |
| 10. | State Street Corporation | 2 years ago | 1973995 |
| 11. | Geode Capital Management, LLC | 2 years ago | 1602595 |
| 12. | Scopia Management Inc | 2 years ago | 1590744 |
| 13. | Rock Springs Capital Management LP | 2 years ago | 1575000 |
| 14. | Marshall Wace Asset Management Ltd | 2 years ago | 1508867 |
| 15. | Nuveen Asset Management, LLC | 2 years ago | 1084033 |
| 16. | Northern Trust Corp | 2 years ago | 756877 |
| 17. | Bank of New York Mellon Corp | 2 years ago | 743700 |
| 18. | Charles Schwab Investment Management Inc | 2 years ago | 598922 |
| 19. | Dimensional Fund Advisors, Inc. | 2 years ago | 570751 |
| 20. | Goldman Sachs Group Inc | 2 years ago | 554168 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...